Search research articles
Contact Us
Filters
Showing results (31-40 of 135) with videos related to
Page
of 14
Sort By:
Acta Endocrinologica
|
July 1, 1980
Inhibition of vasopressin secretion by a met-enkephalin (FK 33-824) in humans
J Brownell, E del Pozo, P Donatsch
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1978
Inhibitory effect of guanfacine, a central alpha-adrenoceptor agonist, on prolactin secretion stimulated by insulin-induced hypoglycemia
I Lancranjan, E del Pozo, E Ohnhaus
American Journal of Obstetrics and Gynecology
|
September 1, 1973
Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility
L Varga, R Wenner, E Del Pozo
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
October 1, 1992
Dynamics of circulating osteocalcin in rats during growth and under experimental conditions
D Modrowski, E del Pozo, L Miravet
Helvetica Chirurgica Acta
|
August 1, 1982
[Value of palliative treatment of metastasizing prostatic cancer with the prolactin inhibitor parlodel]
R Ausfeld, P Huber, E Del Pozo
Schweizerische Medizinische Wochenschrift
|
June 9, 1973
Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report
E Del Pozo, H Friesen, P Burmeister
European Journal of Pharmacology
|
January 12, 1993
ATP-dependent K+ channel blockers antagonize morphine- but not U-504,88H-induced antinociception
M Ocaña, E Del Pozo, J M Baeyens
Psychopharmacology
|
June 1, 1996
The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice
E Del Pozo, M Barrios, J M Baeyens
Pharmacology & Toxicology
|
August 1, 1990
Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice
E Del Pozo, M Barrios, J M Baeyens
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1987
SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years
S W Lamberts, P Uitterlinden, E del Pozo
Page
of 14
Search research articles
Search
Showing results (31-40 of 135) with videos related to
Sort By:
Page
of 14
Acta Endocrinologica
|
July 1, 1980
Inhibition of vasopressin secretion by a met-enkephalin (FK 33-824) in humans
J Brownell, E del Pozo, P Donatsch
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1978
Inhibitory effect of guanfacine, a central alpha-adrenoceptor agonist, on prolactin secretion stimulated by insulin-induced hypoglycemia
I Lancranjan, E del Pozo, E Ohnhaus
American Journal of Obstetrics and Gynecology
|
September 1, 1973
Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility
L Varga, R Wenner, E Del Pozo
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
October 1, 1992
Dynamics of circulating osteocalcin in rats during growth and under experimental conditions
D Modrowski, E del Pozo, L Miravet
Helvetica Chirurgica Acta
|
August 1, 1982
[Value of palliative treatment of metastasizing prostatic cancer with the prolactin inhibitor parlodel]
R Ausfeld, P Huber, E Del Pozo
Schweizerische Medizinische Wochenschrift
|
June 9, 1973
Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report
E Del Pozo, H Friesen, P Burmeister
European Journal of Pharmacology
|
January 12, 1993
ATP-dependent K+ channel blockers antagonize morphine- but not U-504,88H-induced antinociception
M Ocaña, E Del Pozo, J M Baeyens
Psychopharmacology
|
June 1, 1996
The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice
E Del Pozo, M Barrios, J M Baeyens
Pharmacology & Toxicology
|
August 1, 1990
Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice
E Del Pozo, M Barrios, J M Baeyens
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1987
SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years
S W Lamberts, P Uitterlinden, E del Pozo
Page
of 14